Lexpos News

Drug alert number: EL(23)A/02 Date issued: 18 January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Dioctyl 100 mg Capsules, UCB Pharma Ltd – PL 00039/0737 Batch Number Expiry Date Pack Size First Distributed 22983D 30 June 2023 1 x 100 capsules 16 December 2021 Active [...]

The post MHRA Class 2 Medicines Recall: Dioctyl 100 mg Capsules (UCB Pharma Ltd) appeared first on PSNC Website.

Leading national pharmacy bodies have agreed to work together on a programme of activities to lobby for fair NHS funding for pharmacies in England, including co-ordinating efforts to mobilise public support. The Save Our Pharmacies campaign will focus on highlighting both the pressures that pharmacies are under and the huge untapped potential of the sector [...]

The post Community pharmacy bodies launch joint influencing campaign appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Vigabatrin (Sabril®) 500mg tablets. MSN/2023/003 Tier 2 – medium impact Date of issue 17th January 2023 Vigabatrin (Sabril®) 500mg tablets are out of stock until w/c 3rd March 2023. An alternative formulation of the Sabril® brand of vigabatrin is the 500mg [...]

The post Medicine Supply Notification: Vigabatrin (Sabril® ) 500mg tablets appeared first on PSNC Website.

Update – 24th February 2023: Insuman® Comb 25 100units/ml suspension for injection 3ml cartridges and prefilled pens will be discontinued with stocks being exhausted in February and June 2023 respectively. Insuman® Basal 100units/ml suspension for injection 3ml cartridges and prefilled pens will be discontinued with stocks being exhausted in February and June 2023 respectively. Insuman® [...]

The post Medicine Supply Notification: Various Insuman Insulin preparations discontinued – Updated appeared first on PSNC Website.

Community pharmacy contractors are now able to update NHS Profile Manager if they routinely hold the 16 palliative and end of life care (PEoLC) medicines listed in the Drug Tariff and can support local access to parenteral haloperidol. This requirement is a criterion in the ‘Addressing unwarranted variation in care’ domain of the 2022/23 Pharmacy [...]

The post PQS: NHS Profile Manager updated for PEoLC criterion appeared first on PSNC Website.